Statera Biopharma, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Statera Biopharma, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2022.
  • Statera Biopharma, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2022 was 50.7M shares, a 58.1% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 50.7M +18.6M +58.1% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 49.6M +34.2M +221% Jun 30, 2022 10-Q 2022-10-28
Q1 2022 50M +34.5M +223% Mar 31, 2022 10-Q 2022-10-21
Q4 2021 35.5M +22.1M +165% Dec 31, 2021 10-Q 2022-11-14
Q3 2021 32.1M +19.1M +147% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 15.5M +2.54M +19.7% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 15.5M +4.07M +35.7% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 13.4M +2.08M +18.4% Dec 31, 2020 10-K 2022-10-06
Q3 2020 13M +1.72M +15.2% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 12.9M +1.63M +14.4% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 11.4M +105K +0.93% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 11.3M 0 0% Dec 31, 2019 10-K 2021-03-22
Q3 2019 11.3M 0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 11.3M 0 0% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 11.3M 0 0% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 11.3M +18.4K +0.16% Dec 31, 2018 10-K 2020-04-15
Q3 2018 11.3M +18.4K +0.16% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 11.3M +18.4K +0.16% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 11.3M +311K +2.83% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 11.3M +293K +2.66% Dec 31, 2017 10-K 2019-03-07
Q3 2017 11.3M +293K +2.66% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 11.3M +293K +2.66% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 11M 0 0% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 11M 0 0% Dec 31, 2016 10-K 2018-03-06
Q3 2016 11M +256K +2.39% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 11M +6.72M +157% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 11M +7.55M +220% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 11M +8.13M +284% Dec 31, 2015 10-K 2017-02-22
Q3 2015 10.7M -46.4M -81.2% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 4.27M -52.8M -92.5% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 3.44M -47.5M -93.3% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 2.86M +598K +26.5% Dec 31, 2014 10-K 2016-02-23
Q3 2014 57.1M +12M +26.5% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 57.1M +12.1M +27% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 50.9M +6.03M +13.4% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 2.26M -42.5M -94.9% Dec 31, 2013 10-K 2015-02-27
Q3 2013 45.2M +9.22M +25.7% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 45M +9.13M +25.5% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 44.9M +9.22M +25.8% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 44.7M +9.12M +25.6% Dec 31, 2012 10-K 2014-03-17
Q3 2012 35.9M +457K +1.29% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 35.8M +463K +1.31% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 35.7M Mar 31, 2012 10-Q 2012-05-07
Q4 2011 35.6M +6.65M +23% Dec 31, 2011 10-K 2013-03-18
Q3 2011 35.5M Sep 30, 2011 10-Q/A 2011-11-14
Q2 2011 35.4M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 29M Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.